Clin2
NCT06473597Possibly a fitRecruiting

Comparing Nurtec and Maxalt for migraine in the ER

Migraine

Treatments studied

Part of Brain & nervous system, Pain clinical trials.

This trial tests two fast-dissolving migraine medicines, Nurtec ODT and Maxalt MLT-ODT, in adults coming to the emergency room with a migraine. The goal is to see which one works better and faster for pain relief.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
80 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You are in the emergency department with a migraine headache that feels like at least a 5 out of 10 on a pain scale.
  • You are awake, alert, and able to understand and talk about the study.
  • You are not allergic to either rimegepant (Nurtec) or rizatriptan (Maxalt).
  • You are not pregnant or breastfeeding, and you do not have certain heart, liver, or blood vessel problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07667621Not yet recruiting· Phase 1
Migraine medicines in the emergency department

This trial tests whether a new class of migraine medicines, called gepants, can relieve migraine pain quickly when given in the emergency department. If you're having a migraine and haven't taken pain medication recently, you might be able to join.

Tampa, Florida
NCT06428838Enrolling by invitation· Phase 3
Add-on migraine treatment for emergency room visits

This study tests an add-on migraine medicine (eptinezumab) given in the emergency room to quickly relieve a migraine attack, in addition to the usual care. It aims to see if this approach reduces pain and prevents the migraine from coming back.

New Westminster, British Columbia
NCT07856056Not yet recruiting· Phase 4
Comparing two antidepressants to prevent migraines

This study compares two common medicines, nortriptyline and amitriptyline, to see which works better at preventing migraines. Both are antidepressants that are often used to stop migraines before they start.

Muscat
NCT07646613Recruiting· Phase 2
Testing an inhaled migraine medicine for quick relief

This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.

Phoenix, Arizona
NCT07645924Recruiting· Phase 3
Elismetrep for fast relief of migraine attacks

This trial tests a new oral medication called elismetrep (K-304) for quickly stopping migraine pain and other symptoms. If you have regular migraines, this could offer a new option that works fast when a migraine starts.

Birmingham, Alabama
NCT04925414Recruiting· Phase 4
Testing high-flow oxygen for migraine in the emergency room

This trial looks at whether breathing high-flow oxygen in the emergency department can help relieve migraine-like headaches. You may qualify if you are 18+ and are admitted to the ER for a migraine that fits standard diagnostic rules.

Nice

Hear when a new Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.